DCF — MOFFITT CANCER CENTER
Enterprise Value: $1.2B
🛡️ Public data only — no PHI permitted on this instance.
← DashboardPRFProfileMEMIC MemoBRGBridgeCIComp IntelSCNScenariosAIMLDCFDCFLBOLBOFIN3-StmtMKTMarketDENDenialRETReturnsLVRLeversWFLWaterfallPLYPlaybookTRDTrendsPREDPredictedMEM2Memo
$1.2B
Enterprise Value
$309.9M
PV of Cash Flows
$907.6M
PV of Terminal Value
$1.5B
Terminal Value
10.0%
WACC
2.5%
Terminal Growth
Cash Flow Projections
PROJ| Year | Revenue | EBITDA | Margin | FCF | PV(FCF) |
|---|---|---|---|---|---|
| Year 1 | $2.0B | $167.2M | 9.0% | $54.4M | $49.5M |
| Year 2 | $2.0B | $192.5M | 10.0% | $71.3M | $58.9M |
| Year 3 | $2.1B | $219.2M | 11.0% | $89.1M | $66.9M |
| Year 4 | $2.2B | $236.5M | 11.0% | $99.8M | $68.2M |
| Year 5 | $2.2B | $249.1M | 11.0% | $106.9M | $66.4M |
Interpretation
INTAt a WACC of 10.0% and terminal growth of 2.5%, enterprise value is $1.2B. Terminal value accounts for 75% of total EV — typical range (60-80%).
Next steps: Check the LBO model to see equity returns at this entry price, or the EBITDA bridge to model value creation levers.
Assumptions
ASSMrevenue base$1.9B
revenue growth rates[0.03, 0.03, 0.03, 0.03, 0.03]
ebitda margin base0.08000000002093953
ebitda margin improvement bps[50, 100, 100, 50, 25]
capex pct revenue0.04
nwc pct revenue0.08
tax rate0.25
projection years5